Skip to Content

'
Amanda Olson, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

I completed Hematology and Oncology fellowship at Memorial Sloan-Kettering in 2013 where my research focus was related to optimization of umbilical cord blood transplantation and infectious complications following hematopoietic stem cell transplant in adults.  I am currently an Assistant Professor of Medicine in the Department of Stem Cell Transplantation and Cellular Therapy where I oversee clinical research related to cord blood transplantation, mesenchymal stem cell manipulation and cellular therapy. I am the Principal Investigator for several cellular therapy trials including a Phase I trial of mesenchymal stem cells transfected with plasmid containing interferon beta for the treatment of refractory epithelial ovarian cancer, an international multi-institutional Phase III study evaluating the use of cord blood derived mesenchymal stem cell expansion to expedite hematopoietic engraftment following stem cell transplantation, a Phase I trial of IV mesenchymal stem cells for the use of cardiac regeneration following chemotherapy induced cardiomyopathy and a Phase II trial of cytotoxic T-lymphocytes the treatment of BK cystitis in stem cell transplant recipients.

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Boulevard
Unit Number: 423
Houston, TX 77030
Room Number: FC5. 3004
Phone: 713-745-1505
Fax: 713-794-4902
Email: alolson@mdanderson.org

Education & Training

Degree-Granting Education

2007 The Medical College of Georgia School of Medicine, Augusta, GA, MD, Internal Medicine
2003 University of Georgia, Athens, GA, BS, Medicine

Postgraduate Training

7/2010-7/2013 Fellowship, Hematology and Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY
7/2008-7/2010 Residency, Internal Medicine, Baylor College of Medicine, Houston, TX
7/2007-7/2008 Internship, Internal Medicine, Baylor College of Medicine, Houston, TX
6/2004-8/2004 Research Fellowship, National Institute of Health, Bethesda, MD

Board Certifications

2010 Internal Medicine

Honors and Awards

2012-2013 The Lymphoma Foundation, Mortimer J. Lacher Fellowship
2012 The Future of Stem Cell Transplantation, American Society of Hematology

Selected Publications

Other Articles
1. A.L. Olson, P. Dahi, J. Zheng, S.M. Devlin, M. Lubin, A.M. Gonzales, S. Giralt, D. Ponce, N.A. Kernan, A. Scaradavou, G. Papanicolaou, J.N. Barker. HHV-6 Viremia is Frequent but the Incidence of Encephalitis is Low in Double-Unit Cord Blood Transplant Recipients Transplanted without ATG. Biology of Blood and Marrow Transplantation 19(2):S125, 2013.
2. P. Dahi, A.L. Olson, S. Devlin, M. Lubin, A.M. Gonzales, K. Evans, A. Scaradavou, N. Kernan, T. Small, R. O'Reilly, S.A. Giralt, G. Koehne, M.A. Perales, D. Ponce, Z. Papanicolaou, & J.N. Barker. Incidence, Nature, Risk Factors and Outcomes of Cytomegalovirus Infection After Double-Unit Cord Blood Transplantation. Biology of Blood and Marrow Transplantation 19(2):S344-S345, 2013.
3. A.L. Olson, R. Lehrman, S.M. Devlin, M. Maloy, H. Castro-Malaspina, S.A. Giralt, J.D. Goldberg, R.J. O'Reilly, M.A. Perales, E.B. Papadopoulos, & A.A. Jakubowski. The Prognostic Significance of Peripheral Blood Mixed Chimerism After T-Cell Depleted Allogeneic Stem Cell Transplant. Biology of Blood and Marrow Transplantation 19(2):S301-302, 2013.
4. A.L. Olson, S.M. Devlin, M. Maloy, R. Lehman, J.N. Barker, H. Castro-Malaspina, S.A. Giralt, JH.D. Goldberg, R.J O'Reilly, M.A. Perales, E.B. Papadopoulos, A.A. Jakubowski. Bone marrow mixed chimerism is a risk factor for relapse after T-cell depleted allogeneic stem cell transplant. Blood, 2012.
5. A.L. Olson, P. Dahi, J. Zheng, S.M. Devlin, M. Lubin, A.M. Gonzales, S. Giralt, D. Ponce, N.A. Kernan, A. Scaradavou, G. Papanicolaou, J.N. Barker. HHV-6 Viremia is Frequent but the Incidence of Encephalitis is Low in Double-Unit Cord Blood Transplant Recipients Transplanted without ATG. Blood, 2012.
6. L.S. Schwartzberg, M. Beeram, A. Patnaik, A.W. Tolcher, L. Itri, A.L. Olson, A.D. Seidman. Tesetaxel, an advanced-generation oral taxane, as first-line treatment in women with metastatic breast cancer. Journal of Clinical Oncology, 2011.
7. A.L. Olson, G.N. Hortobagyi, K.M. Hahn. Cervical and colorectal screening among breast cancer survivors followed in either a breast center of a breast survivorship clinic at The University of Texas M.D. Anderson Cancer Center. Journal of Clinical Oncology, 2009.

Grant & Contract Support

Title: Mesenchymal Stem Cells as Tumor-Tropic Vehicles for Ovarian Cancer Treatment
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Bast
Duration: 2010 - 2015

Last updated: 11/24/2014